<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>public and global health</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>public and global health | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Genomic epidemiology of the cholera outbreak in Malawi 2022-2023
Authors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/public-and-global-health/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="public and global health" />
<meta property="og:description" content="Genomic epidemiology of the cholera outbreak in Malawi 2022-2023
Authors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/public-and-global-health/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-09-06T10:39:07+00:00" />
<meta property="article:modified_time" content="2023-09-06T10:39:07+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="public and global health"/>
<meta name="twitter:description" content="Genomic epidemiology of the cholera outbreak in Malawi 2022-2023
Authors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "public and global health",
      "item": "https://trxiv.yorks0n.com/posts/public-and-global-health/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "public and global health",
  "name": "public and global health",
  "description": "Genomic epidemiology of the cholera outbreak in Malawi 2022-2023\nAuthors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M.",
  "keywords": [
    
  ],
  "articleBody": " Genomic epidemiology of the cholera outbreak in Malawi 2022-2023\nAuthors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M.; Malolo, I.; Mwanyongo, A.; Mvula, B.; Nyenje, M.; de Oliveira, T.; Kagoli, M.\nScore: 49.1, Published: 2023-08-24 DOI: 10.1101/2023.08.22.23294324\nSince early 2022, in the aftermath of two extreme weather events, Malawi experienced its largest ever cholera outbreak, with over 58,000 reported cases and 1,761 deaths as of May 2023. We generated 49 high-quality, near-complete Vibrio cholerae genomes in Malawi from isolates collected between December 2022 and March 2023 from all three regions of Malawi. Using phylogenetic methods with 2159 publicly available genomes, we present evidence suggesting that the Malawi outbreak strains originated from the Pakistan outbreak, the estimated most recent ancestor of this lineage, named T15, was during the Pakistan floods, and once introduced into Malawi was exacerbated by major floods between June and October 2022. The extreme weather events and humanitarian crises in Malawi provided the environment for the spread of Vibrio cholerae, and the subsequent movement of large numbers of people may have facilitated its spread to susceptible populations in areas relatively unaffected by cholera for over a decade.\nHigh-Dose Naloxone Formulations Are Not as Essential as We Thought\nAuthors: Lemen, P. M.; Garrett, D. P.; Thompson, E.; Aho, M.; Vasquez, C.; Park, J.\nScore: 18.1, Published: 2023-08-14 DOI: 10.1101/2023.08.07.23293781\nNaloxone is a U.S. Food and Drug Administration (FDA) approved opioid antagonist for reversing opioid overdoses. Naloxone is available to the public, and can be administered through intramuscular (IM), intravenous (IV), and intranasal spray (IN) routes. Our literature review aimed to improve understanding regarding the adequacy of the regularly distributed two doses of low-dose IM or IN naloxone in effectively reversing fentanyl overdoses and whether high-dose naloxone formulations (HDNF) formulations are an optimal solution to this problem. Moreover, our initiative incorporated the perspectives and experiences of people who use drugs (PWUD), enabling a more practical and contextually-grounded analysis. We began by discussing the knowledge and perspectives of Tennessee Harm Reduction, a small peer-led harm reduction organization. A comprehensive literature review was then conducted to gather relevant scholarly works on the subject matter. The evidence indicates that, although higher doses of naloxone have been administered in both clinical and community settings, the vast majority of fentanyl overdoses can be successfully reversed using standard IM dosages with the exception of carfentanil overdoses and other more potent fentanyl analogs, which necessitate three or more doses for effective reversal. Multiple studies documented the risk of precipitated withdrawal using high doses of naloxone. Notably, the possibility of recurring overdose symptoms after resuscitation exists, contingent upon the half-life of the specific opioid. Considering these findings and the current community practice of distributing multiple doses, we recommend providing at least four standard doses of IN or IM naloxone to each potential bystander, and training them to continue administration until the recipient achieves stability, ensuring appropriate intervals between each dose. Based on the evidence, we do not recommend HDNF in the place of providing four doses of standard naloxone due to the higher cost, risk of precipitated withdrawal and limited evidence compared to standard IN and IM. All results must be taken into consideration with the inclusion of the lived experiences, individual requirements, and consent of PWUD as crucial factors. It is imperative to refrain from formulating decisions concerning PWUD in their absence, as their participation and voices should be integral to the decision-making process.\nPrevalence and pattern of Post Covid-19 symptoms in recovered patients of Delhi: A Population-Based study\nAuthors: Bhatnagar, N.; Singh, M. M.; Sharma, H.; Mishra, S.; Singh, G.; Rao, S.; Borle, A.; Anand, T.; Kumar, N.; Goswami, B.; Singh, S.; Kapoor, M.; Singla, S.; Khuraijam, B.; Khurana, N.; Sharma, U.; Garg, S.\nScore: 39.4, Published: 2023-08-28 DOI: 10.1101/2023.08.25.23294654\nBackgroundPost-coronavirus disease (COVID) is widely reported but the data of Post COVID-19 after infection with the Omicron variant is limited. This prospective study was conducted to determine the prevalence, pattern, and duration of symptoms related to Covid-19 recovered patients. Methods: Adults (\u003e18 years old) in 11 districts of Delhi who had recovered from Covid-19 were followed up at 3 months and 6 months post-recovery. Results: The study found that the participants had a mean age of 42.07 years, with a standard deviation of 14.89. Additionally, a significant proportion of the participants (79.7%) experienced post-Covid symptoms. The participants elicited a history of Joint Pain (36%), Persistent dry cough (35.7%), anxiousness (28.4%) and shortness of breath (27.1%). The other symptoms reported were persistent fatigue (21.6%), persistent headache (20%), forgetfulness (19.7%) and weakness in limbs (18.6%). The longest duration of symptom was observed in participants reporting anxiousness (138.75 {+/-}54.14) followed by fatigue (137.57{+/-}48.33), shortness of breath (131.89{+/-}60.21) and joint pain/swelling (131.59{+/-}58.76). During the first follow-up, 2.2% of participants had an abnormal ECG reading, while no abnormalities were reported during the second follow-up. Additionally, 4.06% of participants had abnormal chest X-ray findings during the first follow-up, with this number decreasing to 2.16% during the second follow-up. Conclusion: Our study concluded that the clinical symptoms persist in participants until 6 months and a multi-system involvement is seen in the post-COVID period. Thus, the findings necessitate long-term, regular follow-ups.\nHow much should we sequence? An analysis of the Swiss SARS- CoV-2 surveillance effort\nAuthors: Wegner, F.; Cabrera Gil, B.; Araud, T.; Beckmann, C.; Beerenwinkel, N.; Bertelli, C.; Carrara, M.; Cerutti, L.; Chen, C.; Cordey, S.; Dumoulin, A.; Du Plessis, L.; Friedli, M.; Gerth, Y.; Greub, G.; Haerri, A.; Hirsch, H.; Howald, C.; Huber, M.; Imhof, A.; Kaiser, L.; Kufner, V.; Leib, S.; Leuzinger, K.; Lleshi, E.; Martinetti Lucchini, G.; Maeusezahl, M.; Moraz, M.; Neher, R.; Nolte, O.; Ramette, A.; Redondo, M.; Risch, L.; Rohner, L.; Roloff, T.; Schlaepfer, P.; Schneider, K.; Singer, F.; Spina, V.; Stadler, T.; Studer, E.; Topolsky, I.; Trkola, A.; Walther, D.; Wohlwend, N.; Zehnder, C.; Ne\nScore: 1.2, Published: 2023-08-31 DOI: 10.1101/2023.08.28.23294715\nBackgroundDuring the SARS-CoV-2 pandemic, many countries directed substantial resources towards genomic surveillance to detect and track viral variants. There is a debate over how much sequencing effort is necessary in national surveillance programs for SARS-CoV-2 and future pandemic threats. AimWe aimed to investigate the effect of reduced sequencing on surveillance outcomes in a large genomic dataset from Switzerland, comprising more than 143k sequences. MethodsWe employed a uniform downsampling strategy using 100 iterations each to investigate the effects of fewer available sequences on the surveillance outcomes: (i) first detection of variants of concern (VOCs), (ii) speed of introduction of VOCs, (iii) diversity of lineages, (iv) first cluster detection of VOCs, (v) density of active clusters, and (vi) geographic spread of clusters. ResultsThe impact of downsampling on VOC detection is disparate for the three VOC lineages, but many outcomes including introduction and cluster detection could be recapitulated even with only 35% of the original sequencing effort. The effect on the observed speed of introduction and first detection of clusters was more sensitive to reduced sequencing effort for some VOCs, in particular Omicron and Delta, respectively. ConclusionA genomic surveillance program needs a balance between societal benefits and costs. While the overall national dynamics of the pandemic could be recapitulated by a reduced sequencing effort, the effect is strongly lineage dependent - something that is unknown at the time of sequencing - and comes at the cost of accuracy, in particular for tracking the emergence of potential VOCs.\nIndividual and spatial determinants of mortality during the Covid-19 pandemic: The case of Belgium in 2020\nAuthors: Bourguignon, M.; Bertrand, A.; Damiens, J.; Doignon, Y.; Eggerickx, T.; Plavsic, A.; Sanderson, J.-P.\nScore: 1.1, Published: 2023-09-05 DOI: 10.1101/2023.09.04.23295014\nContext. The year 2020 was marked by the Covid 19 pandemic. In Belgium, it led to a doubling in deaths, mainly grouped into two periods. This article aims to compare the relative importance of predictors and individual and spatial determinants of mortality during these two waves to an equivalent non-pandemic period and to identify whether and to what extent the pandemic has altered the sociodemographic patterns of conventional mortality. Methods. The analyses relate to all-cause mortality during the two waves of Covid-19 and their equivalent in 2019. They are based on matching individual and exhaustive data from the Belgian National Register with tax and population census data. A multi-level approach was adopted combining individual and spatial determinants. Results. Mortality patterns during the pandemic are very similar to those observed outside the pandemic. As in 2019, age, sex, and household composition significantly determine the individual risk of dying, with a higher risk of death among the oldest people, men, and residents of collective households. However, their risk of death increases during the Covid period, especially in the 65/79 age group. Spatial information is no more significant in 2020 than in 2019. However, a higher risk of death is observed when the local excess mortality index or the proportions of isolated or disadvantaged people increase. Conclusions. While the Covid pandemic did not fundamentally alter conventional mortality patterns, it did amplify some of the pre-existing differences in mortality.\nParental intention, attitudes, beliefs, trust and deliberation towards childhood vaccination in the Netherlands in 2022: Indications of change compared to 2013\nAuthors: Knijff, M.; van Lier, A.; Boer, M.; de Vries, M.; Hament, J.-M.; de Melker, H. E.\nScore: 1.5, Published: 2023-08-10 DOI: 10.1101/2023.07.24.23291934\nBackground and aimVaccine uptake within the Dutch National Immunisation Programme (NIP) has slightly declined since the COVID-19 pandemic. We studied psychosocial factors of vaccine uptake, namely parental intention, attitudes, beliefs, trust and deliberation (i.e., self-evidence), before (2013) and two years into the pandemic (2022). MethodsIn 2022 and 2013, parents with a young child (aged \u003c3.5 years) participated in online surveys on vaccination (n=1,000 and 800, (estimated) response=12.2% and 37.2%, respectively). Psychosocial factors were measured on 7-point Likert scales. Multivariate logistic regression analysis was used to study differences between parents in 2022 and 2013 in negative scores ([\u0026le;]2) of psychosocial factors. ResultsIn both 2022 and 2013, most parents with a young child expressed positive intention (2022=83.1%, 2013=87.0%), attitudes (3 items: 2022=66.7%-70.9%, 2013=62.1%-69.8%) and trust (2022=51.8%, 2013=52.0%) towards the NIP and felt that vaccinating their child was self-evident (2022=57.2%, 2013=67.3%). Compared to parents with a young child in 2013, parents with a young child in 2022 had significantly higher odds of reporting negative attitudes towards vaccination (3 items combined: OR=2.84), believing that vaccinations offer insufficient protection (OR=4.89), that the NIP is not beneficial for the protection of their childs health (OR=2.23), that vaccinating their child does not necessarily protect the health of other children (OR=2.24) or adults (OR=2.22) and that vaccinations could cause severe side effects (OR=2.20), preferring natural infection over vaccination (OR=3.18) and reporting low trust towards the NIP (OR=1.73). ConclusionsAlthough most parents had positive intention, attitudes and trust towards vaccination and perceived vaccinating their child as self-evident, proportions of parents with negative scores were slightly larger in 2022 compared to 2013. Monitoring these determinants of vaccine uptake and developing appropriate interventions could contribute to sustaining high vaccine uptake.\n",
  "wordCount" : "1864",
  "inLanguage": "en",
  "datePublished": "2023-09-06T10:39:07Z",
  "dateModified": "2023-09-06T10:39:07Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/public-and-global-health/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      public and global health
    </h1>
    <div class="post-meta"><span>updated on September 6, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.22.23294324">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.22.23294324" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.22.23294324">
        <p class="paperTitle">Genomic epidemiology of the cholera outbreak in Malawi 2022-2023</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.22.23294324" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.22.23294324" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Chabuka, L.; Choga, W. T.; Mavian, C. N.; Moir, M.; Tegally, H.; Wilkinson, E.; Naidoo, Y.; Inward, R.; Morgenstern, C.; Bhatt, S.; Wint, W. G. R.; Khan, K.; Bogoch, I. I.; Kraemer, M. U. G.; Baxter, C.; Tagliamonte, M.; Salemi, M.; Lessells, R.; Mitambo, C.; Chitatanga, R.; Bango, J. B.; Chiwaula, M.; Chavula, Y.; Bukhu, M.; Manda, H.; Chitenje, M.; Malolo, I.; Mwanyongo, A.; Mvula, B.; Nyenje, M.; de Oliveira, T.; Kagoli, M.</p>
        <p class="info">Score: 49.1, Published: 2023-08-24 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.22.23294324' target='https://doi.org/10.1101/2023.08.22.23294324'> 10.1101/2023.08.22.23294324</a></p>
        <p class="abstract">Since early 2022, in the aftermath of two extreme weather events, Malawi experienced its largest ever cholera outbreak, with over 58,000 reported cases and 1,761 deaths as of May 2023. We generated 49 high-quality, near-complete Vibrio cholerae genomes in Malawi from isolates collected between December 2022 and March 2023 from all three regions of Malawi. Using phylogenetic methods with 2159 publicly available genomes, we present evidence suggesting that the Malawi outbreak strains originated from the Pakistan outbreak, the estimated most recent ancestor of this lineage, named T15, was during the Pakistan floods, and once introduced into Malawi was exacerbated by major floods between June and October 2022. The extreme weather events and humanitarian crises in Malawi provided the environment for the spread of Vibrio cholerae, and the subsequent movement of large numbers of people may have facilitated its spread to susceptible populations in areas relatively unaffected by cholera for over a decade.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.07.23293781">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.07.23293781" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.07.23293781">
        <p class="paperTitle">High-Dose Naloxone Formulations Are Not as Essential as We Thought</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.07.23293781" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.07.23293781" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Lemen, P. M.; Garrett, D. P.; Thompson, E.; Aho, M.; Vasquez, C.; Park, J.</p>
        <p class="info">Score: 18.1, Published: 2023-08-14 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.07.23293781' target='https://doi.org/10.1101/2023.08.07.23293781'> 10.1101/2023.08.07.23293781</a></p>
        <p class="abstract">Naloxone is a U.S. Food and Drug Administration (FDA) approved opioid antagonist for reversing opioid overdoses. Naloxone is available to the public, and can be administered through intramuscular (IM), intravenous (IV), and intranasal spray (IN) routes. Our literature review aimed to improve understanding regarding the adequacy of the regularly distributed two doses of low-dose IM or IN naloxone in effectively reversing fentanyl overdoses and whether high-dose naloxone formulations (HDNF) formulations are an optimal solution to this problem. Moreover, our initiative incorporated the perspectives and experiences of people who use drugs (PWUD), enabling a more practical and contextually-grounded analysis. We began by discussing the knowledge and perspectives of Tennessee Harm Reduction, a small peer-led harm reduction organization. A comprehensive literature review was then conducted to gather relevant scholarly works on the subject matter. The evidence indicates that, although higher doses of naloxone have been administered in both clinical and community settings, the vast majority of fentanyl overdoses can be successfully reversed using standard IM dosages with the exception of carfentanil overdoses and other more potent fentanyl analogs, which necessitate three or more doses for effective reversal. Multiple studies documented the risk of precipitated withdrawal using high doses of naloxone. Notably, the possibility of recurring overdose symptoms after resuscitation exists, contingent upon the half-life of the specific opioid. Considering these findings and the current community practice of distributing multiple doses, we recommend providing at least four standard doses of IN or IM naloxone to each potential bystander, and training them to continue administration until the recipient achieves stability, ensuring appropriate intervals between each dose. Based on the evidence, we do not recommend HDNF in the place of providing four doses of standard naloxone due to the higher cost, risk of precipitated withdrawal and limited evidence compared to standard IN and IM. All results must be taken into consideration with the inclusion of the lived experiences, individual requirements, and consent of PWUD as crucial factors. It is imperative to refrain from formulating decisions concerning PWUD in their absence, as their participation and voices should be integral to the decision-making process.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.25.23294654">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.25.23294654" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.25.23294654">
        <p class="paperTitle">Prevalence and pattern of Post Covid-19 symptoms in recovered patients of Delhi: A Population-Based study</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.25.23294654" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.25.23294654" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Bhatnagar, N.; Singh, M. M.; Sharma, H.; Mishra, S.; Singh, G.; Rao, S.; Borle, A.; Anand, T.; Kumar, N.; Goswami, B.; Singh, S.; Kapoor, M.; Singla, S.; Khuraijam, B.; Khurana, N.; Sharma, U.; Garg, S.</p>
        <p class="info">Score: 39.4, Published: 2023-08-28 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.25.23294654' target='https://doi.org/10.1101/2023.08.25.23294654'> 10.1101/2023.08.25.23294654</a></p>
        <p class="abstract">BackgroundPost-coronavirus disease (COVID) is widely reported but the data of Post COVID-19 after infection with the Omicron variant is limited. This prospective study was conducted to determine the prevalence, pattern, and duration of symptoms related to Covid-19 recovered patients. Methods: Adults (&gt;18 years old) in 11 districts of Delhi who had recovered from Covid-19 were followed up at 3 months and 6 months post-recovery. Results: The study found that the participants had a mean age of 42.07 years, with a standard deviation of 14.89. Additionally, a significant proportion of the participants (79.7%) experienced post-Covid symptoms. The participants elicited a history of Joint Pain (36%), Persistent dry cough (35.7%), anxiousness (28.4%) and shortness of breath (27.1%). The other symptoms reported were persistent fatigue (21.6%), persistent headache (20%), forgetfulness (19.7%) and weakness in limbs (18.6%). The longest duration of symptom was observed in participants reporting anxiousness (138.75 {&#43;/-}54.14) followed by fatigue (137.57{&#43;/-}48.33), shortness of breath (131.89{&#43;/-}60.21) and joint pain/swelling (131.59{&#43;/-}58.76). During the first follow-up, 2.2% of participants had an abnormal ECG reading, while no abnormalities were reported during the second follow-up. Additionally, 4.06% of participants had abnormal chest X-ray findings during the first follow-up, with this number decreasing to 2.16% during the second follow-up. Conclusion: Our study concluded that the clinical symptoms persist in participants until 6 months and a multi-system involvement is seen in the post-COVID period. Thus, the findings necessitate long-term, regular follow-ups.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.28.23294715">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.28.23294715" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.28.23294715">
        <p class="paperTitle">How much should we sequence? An analysis of the Swiss SARS- CoV-2 surveillance effort</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.28.23294715" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.28.23294715" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wegner, F.; Cabrera Gil, B.; Araud, T.; Beckmann, C.; Beerenwinkel, N.; Bertelli, C.; Carrara, M.; Cerutti, L.; Chen, C.; Cordey, S.; Dumoulin, A.; Du Plessis, L.; Friedli, M.; Gerth, Y.; Greub, G.; Haerri, A.; Hirsch, H.; Howald, C.; Huber, M.; Imhof, A.; Kaiser, L.; Kufner, V.; Leib, S.; Leuzinger, K.; Lleshi, E.; Martinetti Lucchini, G.; Maeusezahl, M.; Moraz, M.; Neher, R.; Nolte, O.; Ramette, A.; Redondo, M.; Risch, L.; Rohner, L.; Roloff, T.; Schlaepfer, P.; Schneider, K.; Singer, F.; Spina, V.; Stadler, T.; Studer, E.; Topolsky, I.; Trkola, A.; Walther, D.; Wohlwend, N.; Zehnder, C.; Ne</p>
        <p class="info">Score: 1.2, Published: 2023-08-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.28.23294715' target='https://doi.org/10.1101/2023.08.28.23294715'> 10.1101/2023.08.28.23294715</a></p>
        <p class="abstract">BackgroundDuring the SARS-CoV-2 pandemic, many countries directed substantial resources towards genomic surveillance to detect and track viral variants. There is a debate over how much sequencing effort is necessary in national surveillance programs for SARS-CoV-2 and future pandemic threats.

AimWe aimed to investigate the effect of reduced sequencing on surveillance outcomes in a large genomic dataset from Switzerland, comprising more than 143k sequences.

MethodsWe employed a uniform downsampling strategy using 100 iterations each to investigate the effects of fewer available sequences on the surveillance outcomes: (i) first detection of variants of concern (VOCs), (ii) speed of introduction of VOCs, (iii) diversity of lineages, (iv) first cluster detection of VOCs, (v) density of active clusters, and (vi) geographic spread of clusters.

ResultsThe impact of downsampling on VOC detection is disparate for the three VOC lineages, but many outcomes including introduction and cluster detection could be recapitulated even with only 35% of the original sequencing effort. The effect on the observed speed of introduction and first detection of clusters was more sensitive to reduced sequencing effort for some VOCs, in particular Omicron and Delta, respectively.

ConclusionA genomic surveillance program needs a balance between societal benefits and costs. While the overall national dynamics of the pandemic could be recapitulated by a reduced sequencing effort, the effect is strongly lineage dependent - something that is unknown at the time of sequencing - and comes at the cost of accuracy, in particular for tracking the emergence of potential VOCs.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.04.23295014">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.04.23295014" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.04.23295014">
        <p class="paperTitle">Individual and spatial determinants of mortality during the Covid-19 pandemic: The case of Belgium in 2020</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.04.23295014" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.04.23295014" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Bourguignon, M.; Bertrand, A.; Damiens, J.; Doignon, Y.; Eggerickx, T.; Plavsic, A.; Sanderson, J.-P.</p>
        <p class="info">Score: 1.1, Published: 2023-09-05 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.04.23295014' target='https://doi.org/10.1101/2023.09.04.23295014'> 10.1101/2023.09.04.23295014</a></p>
        <p class="abstract">Context. The year 2020 was marked by the Covid 19 pandemic. In Belgium, it led to a doubling in deaths, mainly grouped into two periods. This article aims to compare the relative importance of predictors and individual and spatial determinants of mortality during these two waves to an equivalent non-pandemic period and to identify whether and to what extent the pandemic has altered the sociodemographic patterns of conventional mortality. Methods. The analyses relate to all-cause mortality during the two waves of Covid-19 and their equivalent in 2019. They are based on matching individual and exhaustive data from the Belgian National Register with tax and population census data. A multi-level approach was adopted combining individual and spatial determinants. Results. Mortality patterns during the pandemic are very similar to those observed outside the pandemic. As in 2019, age, sex, and household composition significantly determine the individual risk of dying, with a higher risk of death among the oldest people, men, and residents of collective households. However, their risk of death increases during the Covid period, especially in the 65/79 age group. Spatial information is no more significant in 2020 than in 2019. However, a higher risk of death is observed when the local excess mortality index or the proportions of isolated or disadvantaged people increase. Conclusions. While the Covid pandemic did not fundamentally alter conventional mortality patterns, it did amplify some of the pre-existing differences in mortality.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.24.23291934">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.24.23291934" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.24.23291934">
        <p class="paperTitle">Parental intention, attitudes, beliefs, trust and deliberation towards childhood vaccination in the Netherlands in 2022: Indications of change compared to 2013</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.24.23291934" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.24.23291934" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Knijff, M.; van Lier, A.; Boer, M.; de Vries, M.; Hament, J.-M.; de Melker, H. E.</p>
        <p class="info">Score: 1.5, Published: 2023-08-10 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.24.23291934' target='https://doi.org/10.1101/2023.07.24.23291934'> 10.1101/2023.07.24.23291934</a></p>
        <p class="abstract">Background and aimVaccine uptake within the Dutch National Immunisation Programme (NIP) has slightly declined since the COVID-19 pandemic. We studied psychosocial factors of vaccine uptake, namely parental intention, attitudes, beliefs, trust and deliberation (i.e., self-evidence), before (2013) and two years into the pandemic (2022).

MethodsIn 2022 and 2013, parents with a young child (aged &lt;3.5 years) participated in online surveys on vaccination (n=1,000 and 800, (estimated) response=12.2% and 37.2%, respectively). Psychosocial factors were measured on 7-point Likert scales. Multivariate logistic regression analysis was used to study differences between parents in 2022 and 2013 in  negative scores ([&amp;le;]2) of psychosocial factors.

ResultsIn both 2022 and 2013, most parents with a young child expressed positive intention (2022=83.1%, 2013=87.0%), attitudes (3 items: 2022=66.7%-70.9%, 2013=62.1%-69.8%) and trust (2022=51.8%, 2013=52.0%) towards the NIP and felt that vaccinating their child was self-evident (2022=57.2%, 2013=67.3%). Compared to parents with a young child in 2013, parents with a young child in 2022 had significantly higher odds of reporting negative attitudes towards vaccination (3 items combined: OR=2.84), believing that vaccinations offer insufficient protection (OR=4.89), that the NIP is not beneficial for the protection of their childs health (OR=2.23), that vaccinating their child does not necessarily protect the health of other children (OR=2.24) or adults (OR=2.22) and that vaccinations could cause severe side effects (OR=2.20), preferring natural infection over vaccination (OR=3.18) and reporting low trust towards the NIP (OR=1.73).

ConclusionsAlthough most parents had positive intention, attitudes and trust towards vaccination and perceived vaccinating their child as self-evident, proportions of parents with negative scores were slightly larger in 2022 compared to 2013. Monitoring these determinants of vaccine uptake and developing appropriate interventions could contribute to sustaining high vaccine uptake.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
